These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31162107)

  • 21. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 22. Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices.
    Bitterman DS; Cagney DN; Singer LL; Nguyen PL; Catalano PJ; Mak RH
    J Natl Cancer Inst; 2020 Mar; 112(3):229-237. PubMed ID: 31504680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.
    Renfro LA; Sargent DJ
    Ann Oncol; 2017 Jan; 28(1):34-43. PubMed ID: 28177494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory landscape for cell therapy--EU view.
    McBlane JW
    Biologicals; 2015 Sep; 43(5):433-6. PubMed ID: 25997566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Joint pilot project of the German higher federal authorities and ethics committees on implementing the EU Regulation on clinical trials].
    Sudhop T; Grass G; Wessler I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):817-825. PubMed ID: 28664274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Master protocol trials in oncology: Review and new trial designs.
    Hirakawa A; Asano J; Sato H; Teramukai S
    Contemp Clin Trials Commun; 2018 Dec; 12():1-8. PubMed ID: 30182068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-marketing authorisation submission assessments in Europe.
    Morgan L
    Therapie; 2005; 60(3):205-8. PubMed ID: 16128260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.
    Huml RA; Collyar D; Antonijevic Z; Beckman RA; Quek RGW; Ye J
    Ther Innov Regul Sci; 2023 Nov; 57(6):1136-1147. PubMed ID: 37615880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of integrated clinical trial protocols in early phases of medicinal product development.
    Fruhner K; Hartmann G; Sudhop T
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1565-1577. PubMed ID: 28921395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncology protocols: how can we do better?
    Kaste SC
    Pediatr Radiol; 2011 May; 41 Suppl 1():S166-9. PubMed ID: 21327772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the need to adjust for multiplicity in confirmatory clinical trials with master protocols.
    Stallard N; Todd S; Parashar D; Kimani PK; Renfro LA
    Ann Oncol; 2019 Apr; 30(4):506-509. PubMed ID: 30715156
    [No Abstract]   [Full Text] [Related]  

  • 33. This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
    Schiavone F; Bathia R; Letchemanan K; Masters L; Amos C; Bara A; Brown L; Gilson C; Pugh C; Atako N; Hudson F; Parmar M; Langley R; Kaplan RS; Parker C; Attard G; Clarke NW; Gillessen S; James ND; Maughan T; Sydes MR;
    Trials; 2019 May; 20(1):264. PubMed ID: 31138317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011-2018.
    Schuster Bruce C; Brhlikova P; Heath J; McGettigan P
    PLoS Med; 2019 Sep; 16(9):e1002873. PubMed ID: 31504034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Completeness of protocols for clinical trials in children submitted to ethics committees.
    Joseph PD; Caldwell PH; Barnes EH; Hynes K; Choong CS; Turner S; Vosk C; White J; Richichi K; Craig JC
    J Paediatr Child Health; 2019 Mar; 55(3):291-298. PubMed ID: 30161286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.
    Perlmutter AS; Tran VT; Dechartres A; Ravaud P
    Ann Oncol; 2017 Apr; 28(4):688-695. PubMed ID: 28011448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting of master protocols towards a standardized approach: A systematic review.
    Siden EG; Park JJ; Zoratti MJ; Dron L; Harari O; Thorlund K; Mills EJ
    Contemp Clin Trials Commun; 2019 Sep; 15():100406. PubMed ID: 31334382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marketing authorisation applications submitted to the European Medicines Agency by small and medium-sized enterprises: an analysis of major objections and their impact on outcomes.
    Amaouche N; Casaert Salomé H; Collignon O; Santos MR; Ziogas C
    Drug Discov Today; 2018 Oct; 23(10):1801-1805. PubMed ID: 29953957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.
    Collignon O; Gartner C; Haidich AB; James Hemmings R; Hofner B; Pétavy F; Posch M; Rantell K; Roes K; Schiel A
    Clin Pharmacol Ther; 2020 May; 107(5):1059-1067. PubMed ID: 32017052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.